Primary Sjögren's syndrome (pSS) has multi-dimensional manifestations, including neutropenia and polyneuropathy. We herein report a 76-year-old woman with pSS initially presenting as severe granulocyte-colony-stimulating factor (G-CSF)-refractory neutropenia and axonal sensorimotor polyneuropathies (SMP). Systemic glucocorticoid administration had reduced neutrophil-associated immunoglobulin G (NAIgG) on the neutrophil surface as detected using flow cytometry, resulting in the development of neutropenia. A patient with pSS concomitant with axonal SMP might show severe neutropenia as aggressive autoimmune disease. Neutropenia can be treated with systemic glucocorticoids based on the assessment of NAIgG on the neutrophil surface.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683808PMC
http://dx.doi.org/10.2169/internalmedicine.9092-21DOI Listing

Publication Analysis

Top Keywords

neutropenia polyneuropathy
8
presenting severe
8
sjögren's syndrome
8
naigg neutrophil
8
neutrophil surface
8
neutropenia
6
granulocyte-colony-stimulating factor-resistant
4
factor-resistant neutropenia
4
polyneuropathy presenting
4
severe complications
4

Similar Publications

Background: Panitumumab has been extensively applied in antitumor therapy, and the regulation of its adverse drug reactions (ADRs) has become extremely important. This study utilized the U.S.

View Article and Find Full Text PDF
Article Synopsis
  • Scrub typhus is a disease caused by mites and is common in the Asia Pacific, leading to serious neurological problems like meningoencephalitis and, in rare cases, CVST.
  • A unique case involved an 18-year-old pregnant woman in India who, after experiencing symptoms like fever and headaches, was found to have CVST stemming from scrub typhus meningoencephalitis; treatment involved azithromycin and later anticoagulation therapy.
  • The report emphasizes the need to consider CVST in pregnant women with severe scrub typhus symptoms even if antibiotics are being used, as early treatment is crucial for better outcomes.
View Article and Find Full Text PDF

Treatment approaches for older Hodgkin lymphoma patients.

Curr Opin Oncol

September 2024

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD).

Purpose Of Review: Hodgkin lymphoma (HL) occurs at two age peaks around 25 and 60 years of age. Due to varying fitness and co-morbidities older patients are a heterogeneous group that has relatively poor treatment outcomes. The evolving therapeutic landscape for older HL is summarized herein.

View Article and Find Full Text PDF

What are the needs in oral antitumor therapy? An analysis of patients' and practitioners' preferences.

Front Oncol

June 2024

Department of Obstetrics and Gynecology, Breast Center and Comprehensive Cancer Center (CCC) Munich, University Hospital, LMU Munich, Munich, Germany.

Background: Since the European approval of CDK4/6 inhibitors in 2016, the treatment of patients with hormone-receptor-positive, HER2-negative metastatic breast cancer has changed significantly. Compared with chemotherapy, endocrine-based therapy has different treatment regimens and is associated with new side effects. Oral therapy aims for optimal drug efficacy and long treatment times while maintaining maximum independence and quality of life resulting in the conservation of medical staff resources.

View Article and Find Full Text PDF
Article Synopsis
  • A study tested a combination treatment called ICD (ixazomib, cyclophosphamide, and dexamethasone) on 12 new patients with a condition called POEMS syndrome.
  • Out of 10 patients that could be checked, 80% had a positive response to the treatment, and 30% showed a complete recovery in their blood.
  • The treatment was found to be safe with only a few patients experiencing serious side effects like diarrhea and low white blood cell count.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!